• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种源自慢性肉芽肿病患者的病原体,产生一种五酰化低刺激性甘氨酰-D-塔罗庚-2-烯酸脂酰脂(Ko-Lipid A)。

, a Pathogen from Patients with Chronic Granulomatous Disease, Produces a Penta-Acylated Hypostimulatory Glycero-D-talo-oct-2-ulosonic Acid-Lipid A Glycolipid (Ko-Lipid A).

机构信息

Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Int J Mol Sci. 2021 Mar 24;22(7):3303. doi: 10.3390/ijms22073303.

DOI:10.3390/ijms22073303
PMID:33804872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036547/
Abstract

can infect patients with chronic granulomatous disease, an immunodeficiency caused by reduced phagocyte NADPH oxidase function. Intact () is hypostimulatory compared to , i.e., cytokine production in human blood requires 10-100 times more CFU/mL than . To better understand the pathogenicity of , we isolated its lipopolysaccharide (LPS) and characterized its lipid A. Unlike with typical , the release of presumptive Gb lipid A from its LPS required a strong acid. NMR and mass spectrometry demonstrated that the carbohydrate portion of the isolated glycolipid consists of α-Man-(1→4)-β-GlcN3N-(1→6)-α-GlcN-(1⇿1)-α-GlcA tetra-saccharide substituted with five acyl chains: the amide-linked N-3' 14:0(3-OH), N-2' 16:0(3-O16:0), and N-2 18:0(3-OH) and the ester-linked O-3 14:0(3-OH) and 16:0. The identification of glycero-d-talo-oct-2-ulosonic acid (Ko) as the first constituent of the core region of the LPS that is covalently attached to GlcpN3N of the lipid backbone may account for the acid resistance of LPS. In addition, the presence of Ko and only five acyl chains may explain the >10-fold lower proinflammatory potency of Ko-lipidA compared to lipid A, as measured by cytokine induction in human blood. These unusual structural properties of the Ko-lipid A glycolipid likely contribute to immune evasion during pathogenesis and resistance to antimicrobial peptides.

摘要

可以感染患有慢性肉芽肿病的患者,这是一种吞噬细胞 NADPH 氧化酶功能降低引起的免疫缺陷。完整的 () 与相比是低刺激的,即人类血液中的细胞因子产生需要比 多 10-100 倍的 CFU/mL。为了更好地理解 的致病性,我们分离了它的脂多糖 (LPS) 并对其脂质 A 进行了表征。与典型的 LPS 不同,从 LPS 中释放假定的 Gb 脂质 A 需要强酸。NMR 和质谱证明,分离的糖脂的碳水化合物部分由 α-Man-(1→4)-β-GlcN3N-(1→6)-α-GlcN-(1⇿1)-α-GlcA 四糖组成,取代了五个酰基链:酰胺连接的 N-3' 14:0(3-OH)、N-2' 16:0(3-O16:0)和 N-2 18:0(3-OH)以及酯连接的 O-3 14:0(3-OH)和 16:0。鉴定甘油-d-塔洛-oct-2-ulosonic 酸 (Ko) 为 LPS 共价连接到脂质主链的 GlcpN3N 的核心区域的第一个成分,可能解释了 LPS 的耐酸性。此外,Ko 和仅五个酰基链的存在可能解释了 Ko-脂质 A 与 脂质 A 相比,促炎效力低 10 倍以上,如人血中细胞因子诱导所测量的。这种 Ko-脂质 A 糖脂的不寻常结构特性可能有助于在发病机制期间逃避免疫和抵抗抗菌肽。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/74127fa0a1e1/ijms-22-03303-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/6eac90491b92/ijms-22-03303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/740d4643b339/ijms-22-03303-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/c7f3e2644ff2/ijms-22-03303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/80cd01ce73fb/ijms-22-03303-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/d1ecb4902dff/ijms-22-03303-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/dac59a287c83/ijms-22-03303-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/74127fa0a1e1/ijms-22-03303-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/6eac90491b92/ijms-22-03303-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/740d4643b339/ijms-22-03303-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/c7f3e2644ff2/ijms-22-03303-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/80cd01ce73fb/ijms-22-03303-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/d1ecb4902dff/ijms-22-03303-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/dac59a287c83/ijms-22-03303-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3876/8036547/74127fa0a1e1/ijms-22-03303-g007.jpg

相似文献

1
, a Pathogen from Patients with Chronic Granulomatous Disease, Produces a Penta-Acylated Hypostimulatory Glycero-D-talo-oct-2-ulosonic Acid-Lipid A Glycolipid (Ko-Lipid A).一种源自慢性肉芽肿病患者的病原体,产生一种五酰化低刺激性甘氨酰-D-塔罗庚-2-烯酸脂酰脂(Ko-Lipid A)。
Int J Mol Sci. 2021 Mar 24;22(7):3303. doi: 10.3390/ijms22073303.
2
Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.先天免疫对抗 Granulibacter bethesdensis,一种新兴的革兰氏阴性细菌病原体。
Infect Immun. 2012 Mar;80(3):975-81. doi: 10.1128/IAI.05557-11. Epub 2011 Dec 19.
3
Characterization of a Novel d-Glycero-d-talo-oct-2-ulosonic acid-substituted Lipid A Moiety in the Lipopolysaccharide Produced by the Acetic Acid Bacterium Acetobacter pasteurianus NBRC 3283.巴氏醋酸杆菌NBRC 3283产生的脂多糖中一种新型d-甘油-d-塔罗-辛-2-酮糖酸取代的脂质A部分的表征
J Biol Chem. 2016 Sep 30;291(40):21184-21194. doi: 10.1074/jbc.M116.751271. Epub 2016 Aug 18.
4
Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.嗜贝氏颗粒杆菌在人巨噬细胞中的早期细胞内运输
Infect Immun. 2017 May 23;85(6). doi: 10.1128/IAI.00847-16. Print 2017 Jun.
5
Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.格兰氏阴性分枝杆菌在缺乏功能性 NADPH 氧化酶的慢性肉芽肿病的单核细胞和巨噬细胞中持续存在。
J Immunol. 2013 Sep 15;191(6):3297-307. doi: 10.4049/jimmunol.1300200. Epub 2013 Aug 16.
6
Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.健康受试者和慢性肉芽肿病患者中性粒细胞中 Granulibacter bethesdensis 感染时的宿主-病原体转录组同步分析。
Infect Immun. 2015 Nov;83(11):4277-92. doi: 10.1128/IAI.00778-15. Epub 2015 Aug 17.
7
Fatal Meningitis in Patient with X-Linked Chronic Granulomatous Disease Caused by Virulent Granulibacter bethesdensis.X 连锁慢性肉芽肿病患者感染毒力较强的贝氏疏螺旋体导致的致命性脑膜炎。
Emerg Infect Dis. 2019 May;25(5):976-979. doi: 10.3201/eid2505.181505.
8
Isolation and structural characterization of a (Kdo-isosteric) D-glycero-α-D-talo-oct-2-ulopyranosidonic acid (Ko) interlinking lipid A and core oligosaccharide in the lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305.分离并结构表征阿克氏菌(Acinetobacter calcoaceticus)NCTC 10305 脂多糖中脂酰化的类脂 A 和核心寡糖之间的(Kdo 异构体) D-甘油-α-D-塔罗-辛吡喃糖二酸(Ko)连接脂质。
Carbohydr Res. 2013 Aug 30;378:63-70. doi: 10.1016/j.carres.2013.05.003. Epub 2013 May 15.
9
Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.新出现的人类病原性醋酸杆菌贝塞斯达颗粒杆菌的基因组序列分析。
J Bacteriol. 2007 Dec;189(23):8727-36. doi: 10.1128/JB.00793-07. Epub 2007 Sep 7.
10
Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.反复发生的贝氏疏螺旋体感染和慢性肉芽肿病。
Emerg Infect Dis. 2010 Sep;16(9):1341-8. doi: 10.3201/eid1609.091800.

引用本文的文献

1
Unravelling the mechanisms causing murepavadin resistance in : lipopolysaccharide alterations and its consequences.揭示导致多黏菌素B甲磺酸盐耐药性的机制:脂多糖改变及其后果
Front Cell Infect Microbiol. 2024 Dec 6;14:1446626. doi: 10.3389/fcimb.2024.1446626. eCollection 2024.
2
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2021-2022.基质辅助激光解吸/电离质谱法分析碳水化合物和糖缀合物:2021 - 2022年最新进展
Mass Spectrom Rev. 2025 May-Jun;44(3):213-453. doi: 10.1002/mas.21873. Epub 2024 Jun 24.
3
Functional neutrophil disorders: Chronic granulomatous disease and beyond.

本文引用的文献

1
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108.巴斯德醋酸杆菌 CIP103108 脂多糖的结构与炎症活性。
Int J Biol Macromol. 2018 Nov;119:1027-1035. doi: 10.1016/j.ijbiomac.2018.08.035. Epub 2018 Aug 8.
2
Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease.一名患有X连锁慢性肉芽肿病的4岁男孩因贝塞斯达颗粒杆菌感染导致暴发性脓毒症
Pediatr Infect Dis J. 2017 Dec;36(12):1165-1166. doi: 10.1097/INF.0000000000001659.
3
Early Intracellular Trafficking of Granulibacter bethesdensis in Human Macrophages.
功能异常的中性粒细胞疾病:慢性肉芽肿病及其他。
Immunol Rev. 2024 Mar;322(1):71-80. doi: 10.1111/imr.13308. Epub 2024 Mar 1.
嗜贝氏颗粒杆菌在人巨噬细胞中的早期细胞内运输
Infect Immun. 2017 May 23;85(6). doi: 10.1128/IAI.00847-16. Print 2017 Jun.
4
Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications.五日热巴尔通体脂多糖(LPS):一种用于体外和体内应用的强效Toll样受体4拮抗剂的结构与特性
Sci Rep. 2016 Sep 27;6:34221. doi: 10.1038/srep34221.
5
Characterization of a Novel d-Glycero-d-talo-oct-2-ulosonic acid-substituted Lipid A Moiety in the Lipopolysaccharide Produced by the Acetic Acid Bacterium Acetobacter pasteurianus NBRC 3283.巴氏醋酸杆菌NBRC 3283产生的脂多糖中一种新型d-甘油-d-塔罗-辛-2-酮糖酸取代的脂质A部分的表征
J Biol Chem. 2016 Sep 30;291(40):21184-21194. doi: 10.1074/jbc.M116.751271. Epub 2016 Aug 18.
6
Methylotroph Infections and Chronic Granulomatous Disease.甲基营养菌感染与慢性肉芽肿病
Emerg Infect Dis. 2016 Mar;22(3):404-9. doi: 10.3201/eid2203.151265.
7
Simultaneous Host-Pathogen Transcriptome Analysis during Granulibacter bethesdensis Infection of Neutrophils from Healthy Subjects and Patients with Chronic Granulomatous Disease.健康受试者和慢性肉芽肿病患者中性粒细胞中 Granulibacter bethesdensis 感染时的宿主-病原体转录组同步分析。
Infect Immun. 2015 Nov;83(11):4277-92. doi: 10.1128/IAI.00778-15. Epub 2015 Aug 17.
8
Chemistry of lipid A: at the heart of innate immunity.脂多糖A的化学性质:先天免疫的核心
Chemistry. 2015 Jan 7;21(2):500-19. doi: 10.1002/chem.201403923. Epub 2014 Oct 29.
9
Kdo hydroxylase is an inner core assembly enzyme in the Ko-containing lipopolysaccharide biosynthesis.Kdo 羟化酶是 Ko 脂多糖生物合成中的核心组装酶。
Biochem Biophys Res Commun. 2014 Sep 26;452(3):789-94. doi: 10.1016/j.bbrc.2014.08.153. Epub 2014 Sep 6.
10
Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.ArnT对脂质A的酶促修饰可保护支气管败血波氏杆菌抵御阳离子肽,且是传播所必需的。
Infect Immun. 2014 Feb;82(2):491-9. doi: 10.1128/IAI.01260-12. Epub 2013 Oct 14.